title: The clinical potential of Affibody-based inhibitors of C5 for therapeutic complement disruption.
authors.affiliation: a Department of Drug Design & Development , Swedish Orphan Biovitrum AB , Stockholm , Sweden.
authors.forename: Magnus M
authors.initials: MM
authors.lastname: Berglund
authors.affiliation: a Department of Drug Design & Development , Swedish Orphan Biovitrum AB , Stockholm , Sweden.
authors.forename: Patrik
authors.initials: P
authors.lastname: Strömberg
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D003182:Complement C5 / Q000037:antagonists & inhibitors* / Q000276:immunology; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003182:Complement C5